Kevin Otipoby – Biography
Last update: December 3, 2025Executive profile
Kevin was Vice President of Research, Immunology for Pandion Therapeutics. Kevin Otipoby joined Seismic Therapeutic in 2021.
Kevin Otipoby is currentlyChief Research Officer at Seismic Therapeutic - View - Seismic Therapeutic org chart
Create your alert
to follow the career of Kevin Otipoby.
Education
Kevin Otipoby has a Bachelor of Arts in Molecular Biology and Biochemistry from Washington University in St. Louis in 1994 and a PhD in Immunology from University of Washington - School of Medicine in 2000.
They have also studied at Washington University in St. Louis :
Find more alumni from Washington University in St. Louis
More about Kevin Otipoby
Selected links
Do you need to know more about Kevin Otipoby? More results.
Participate
Social media
- Kevin Otipoby on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kevin Otipoby
The colleagues of Kevin Otipoby
Company Colleagues
- At Seismic Therapeutic, Kevin Otipoby has 13 colleagues including Jo Viney (CEO & Director), Tim Springer (Director)…
Industry Colleagues
- In the Biotechnology industry, Kevin Otipoby has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Kevin Otipoby.
Get in Touch
Here are a few tips for establishing great contacts.
